--2025/Q1-- / 7.370M--
--2024/Q4-- / 8.018M--
--2024/Q311.607M / 8.066M--
--2024/Q219.875M / 7.632M--
--2024/Q16.471M / 7.505M--
MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
TNGX Tango Therapeutics
- 3.100
- +0.160+5.44%
Close Dec 20 16:00 ET
- 3.000
- -0.100-3.23%
Post 20:01 ET
333.00MMarket Cap-2.70P/E (TTM)
3.130High2.800Low2.82MVolume2.910Open2.940Pre Close8.69MTurnover5.63%Turnover RatioLossP/E (Static)107.42MShares13.00552wk High1.45P/B155.09MFloat Cap2.70052wk Low--Dividend TTM50.03MShs Float18.840Historical High--Div YieldTTM11.22%Amplitude2.470Historical Low3.084Avg Price1Lot Size
Tango Therapeutics Key Stats
Tango Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Tango Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data